The Alaris system is an infusion pump and vital signs-monitoring system. The pumps deliver controlled amounts of fluids, medications, blood and blood products to patients.
Becton Dickinson, based in Franklin Lakes, N.J., said it found multiple system errors, software errors and use-related errors that can lead to infusion delays and interruptions of infusion and slower or faster than expected delivery of medication.
The FDA classified the recall as Class I, the most serious type, meaning use of the recalled products can cause serious injury or death.
Read the full news release here.
More articles on supply chain:
Amazon, Walmart fighting price-gouging on coronavirus supplies
Rural hospitals taking drastic steps to get supplies amid coronavirus outbreak
Thermo Fisher to acquire Qiagen in $11.5B deal
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
